This work was supported by the NCI (R01CA151570, R01CA237664). The authors thank the entire GYN oncology group led by Dr. Mathew Powell for helping with recruiting patients, radiologists Drs. Cary Siegel, William Middleton, and Malak Itnai for helping with the US studies, and the pathologist Dr. Ian Hagemann for helping with the pathology interpretation of the data. The authors gratefully acknowledge the efforts of Megan Luther and the GYN study coordinators in coordinating the study schedules, identifying patients for the study, and obtaining informed consent.

All the research performed was approved by the Washington University Institutional Review Board.
1. System configuration: Optical illumination (Figure 1)
<ol>
	<li>Use an Nd:YAG laser pumping a pulsed, tunable (690-890 nm) Ti-sapphire laser at 10 Hz.</li>
	<li>Expand the laser beam by first diverging the beam with a plano-concave lens and then collimating the beam with a plano-convex lens. Use two mirrors to direct the beam onto...

<ol>
	<li>Nandy, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Evaluation+of+ovarian+cancer:+Initial+application+of+coregistered+photoacoustic+tomography+and+US.">Evaluation of ovarian cancer: Initial application of coregistered photoacoustic tomography and US.</a> Radiology. 289 (3), 740-747 (2018).</li><li>Amidi, E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Role+of+blood+oxygenation+saturation+in+ovarian+cancer+diagnosis+using+multi-spectral+photoacoustic+tomography.">Role of blood oxygenation saturation in ovarian cancer diagnosis using multi-spectral photoacoustic tomography.</a> Journal of Biophotonics. 14 (4), 202000368 (2021).</li><li>Dogan, B. E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Optoacoustic+imaging+and+gray-scale+US+features+of+breast+cancers:+Correlation+with+molecular+subtypes.">Optoacoustic imaging and gray-scale US features of breast cancers: Correlation with molecular subtypes.</a> Radiology. 292 (3), 564-572 (2019).</li><li>Menezes, G. L. G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Downgrading+of+breast+masses+suspicious+for+cancer+by+using+optoacoustic+breast+imaging.">Downgrading of breast masses suspicious for cancer by using optoacoustic breast imaging.</a> Radiology. 288 (2), 355-365 (2018).</li><li>Neuschler, E. I., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+pivotal+study+of+optoacoustic+imaging+to+diagnose+benign+and+malignant+breast+masses:+A+new+evaluation+tool+for+radiologists.">A pivotal study of optoacoustic imaging to diagnose benign and malignant breast masses: A new evaluation tool for radiologists.</a> Radiology. 287 (2), 398-412 (2018).</li><li>von Knorring, T., Mogensen, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Photoacoustic+tomography+for+assessment+and+quantification+of+cutaneous+and+metastatic+malignant+melanoma+-+A+systematic+review.">Photoacoustic tomography for assessment and quantification of cutaneous and metastatic malignant melanoma - A systematic review.</a> Photodiagnosis and Photodynamic Therapy. 33, 102095 (2021).</li><li>Han, S., Lee, H., Kim, C., Kim, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Review+on+multispectral+photoacoustic+analysis+of+cancer:+Thyroid+and+breast.">Review on multispectral photoacoustic analysis of cancer: Thyroid and breast.</a> Metabolites. 12 (5), 382 (2022).</li><li>Kim, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Multiparametric+photoacoustic+analysis+of+human+thyroid+cancers+in+vivo.">Multiparametric photoacoustic analysis of human thyroid cancers in vivo.</a> Cancer Research. 81 (18), 4849-4860 (2021).</li><li>Basij, M., Karpiouk, A., Winer, I., Emelianov, S., Mehrmohammadi, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Dual-illumination+ultrasound/photoacoustic+system+for+cervical+cancer+imaging.">Dual-illumination ultrasound/photoacoustic system for cervical cancer imaging.</a> IEEE Photonics Journal. 13 (1), 6900310 (2021).</li><li>Agrawal, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=development,+and+multi-characterization+of+an+integrated+clinical+transrectal+ultrasound+and+photoacoustic+device+for+human+prostate+imaging.">development, and multi-characterization of an integrated clinical transrectal ultrasound and photoacoustic device for human prostate imaging.</a> Diagnostics. 10 (8), 566 (2020).</li><li>Kothapalli, S. -. R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Simultaneous+transrectal+ultrasound+and+photoacoustic+human+prostate+imaging.">Simultaneous transrectal ultrasound and photoacoustic human prostate imaging.</a> Science Translational Medicine. 11 (507), 2169 (2019).</li><li>Leng, X., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Assessing+rectal+cancer+treatment+response+using+coregistered+endorectal+photoacoustic+and+US+imaging+paired+with+deep+learning.">Assessing rectal cancer treatment response using coregistered endorectal photoacoustic and US imaging paired with deep learning.</a> Radiology. 299 (2), 349-358 (2021).</li><li>Surveillance, Epidemiology, and End Results Program. Cancer of the Ovary - Cancer Stat Facts. National Cancer Institute Available from: <a target="_blank" href="https://seer.cancer.gov/statfacts/html/ovary.html">https://seer.cancer.gov/statfacts/html/ovary.html</a> (2022)</li><li>Temkin, S. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Outcomes+from+ovarian+cancer+screening+in+the+PLCO+trial:+Histologic+heterogeneity+impacts+detection,+overdiagnosis+and+survival.">Outcomes from ovarian cancer screening in the PLCO trial: Histologic heterogeneity impacts detection, overdiagnosis and survival.</a> European Journal of Cancer. 87, 182-188 (2017).</li><li>Kobayashi, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+randomized+study+of+screening+for+ovarian+cancer:+A+multicenter+study+in+Japan.">A randomized study of screening for ovarian cancer: A multicenter study in Japan.</a> International Journal of Gynecological Cancer. 18 (3), 414-420 (2008).</li><li>Andreotti, R. F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=O-RADS+US+risk+stratification+and+management+system:+A+consensus+guideline+from+the+ACR+ovarian-adnexal+reporting+and+data+system+committee.">O-RADS US risk stratification and management system: A consensus guideline from the ACR ovarian-adnexal reporting and data system committee.</a> Radiology. 294 (1), 168-185 (2020).</li><li>Salehi, H. S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Design+of+optimal+light+delivery+system+for+coregistered+transvaginal+ultrasound+and+photoacoustic+imaging+of+ovarian+tissue.">Design of optimal light delivery system for coregistered transvaginal ultrasound and photoacoustic imaging of ovarian tissue.</a> Photoacoustics. 3 (3), 114-122 (2015).</li><li>Oppenheim, A. V., Schafer, R. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=.">.</a> Digital Signal Processing. , (1975).</li><li>Zou, Y., Amidi, E., Luo, H., Zhu, Q. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Ultrasound-enhanced+Unet+model+for+quantitative+photoacoustic+tomography+of+ovarian+lesions.">Ultrasound-enhanced Unet model for quantitative photoacoustic tomography of ovarian lesions.</a> Photoacoustics. 28, 100420 (2022).</li><li>Prince, J. L., Links, J. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=.">.</a> Medical Imaging Signals and Systems. , (2006).</li><li>Kim, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Programmable+Real-time+Clinical+Photoacoustic+and+Ultrasound+Imaging+System.">Programmable Real-time Clinical Photoacoustic and Ultrasound Imaging System.</a> Scientific Reports. 6, 35137 (2016).</li></ol>

The authors have no relevant financial interests in the manuscript and no other potential conflicts of interest to disclose.

Optical illumination 
The number of fibers used is based on two factors: light illumination uniformity and system complexity. It is critical to have a uniform light illumination pattern at the skin surface to avoid hot spots. It is also important to keep the system simple and robust with a minimal number of fibers. The use of four separate fibers has previously been shown to be optimal for creating uniform illumination at depths of several millimeters and beyond. Additionally, the light coupling to ...

Photoacoustic imaging or tomography (PAT) is a hybrid imaging modality that measures the optical absorption distribution at US resolution and depths far beyond the tissue optical diffusion limit (~1 mm). In PAT, a nanosecond laser pulse is used to excite biological tissue, causing a transient temperature rise due to optical absorption. This leads to an initial pressure rise, and the resultant photoacoustic waves are measured by US transducers. Multispectral PAT involves the use of either a tunable laser or multiple lasers operating at different wavelengths to illuminate the tissue, thereby enabling the reconstruction of optical absorption maps at multiple wavelengths. Based on the differential absorption of oxygenated and deoxygenated hemoglobin in the near-infrared (NIR) window, multispectral PAT can compute the distributions of oxygenated and deoxygenated hemoglobin concentrations, the total hemoglobin concentration, and the blood oxygen saturation, which are all functional biomarkers related to tumor angiogenesis and blood oxygenation consumption or tumor metabolism. PAT has demonstrated success in many oncology applications, such as ovarian cancer1,2, breast cancer3,4,5, skin cancer6, thyroid cancer7,8, cervical cancer9, prostate cancer10,11, and colorectal cancer12.
Ovarian cancer is the deadliest of all gynecological malignancies. Only 38% of ovarian cancers are diagnosed at an early (localized or regional) stage, where the 5 year survival rate is 74.2% to 93.1%. Most are diagnosed at a late stage, for which the 5 year survival rate is 30.8% or less13. Current clinical diagnosis methods, including transvaginal ultrasonography (TUS), Doppler US, serum cancer antigen 125 (CA 125), and human epididymis protein 4 (HE4), are shown to lack sensitivity and specificity for early ovarian cancer diagnosis14,15,16. Additionally, a large portion of benign ovarian lesions may be difficult to diagnose accurately with current imaging technologies, which leads to unnecessary surgeries with increased healthcare costs and surgical complications. Thus, additional accurate non-invasive methods for the risk stratification of adnexal masses are needed to optimize the management and outcomes. Clearly, a technique that is sensitive and specific to early-stage ovarian cancer and more accurate in identifying malignant from benign lesions is needed.
Our group has developed a coregistered transvaginal US and PAT system (USPAT) for ovarian cancer diagnosis by combining a clinical US system, a custom-made probe sheath to house the optical fibers for light delivery, and a tunable laser1. The total hemoglobin concentration (relative scale, rHbT) and the blood oxygen saturation (%sO2) derived from the USPAT system have demonstrated great potential for the detection of early-stage ovarian cancers and for accurately diagnosing ovarian lesions for effective risk assessment and the reduction of unnecessary benign lesion surgeries1,2. The current system schematic is shown in Figure 1, and the control block diagram is shown in Figure 2. This strategy has the potential to be integrated into existing TUS protocols for ovarian cancer diagnosis while providing functional parameters (rHbT, %sO2) to improve the sensitivity and specificity of TUS.

<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr>
			<td>Clinical US imaging system</td>
			<td>Alpinion Medical Systems</td>
			<td>EC-12R</td>
			<td>Fully programmable clinical US system</td>
		</tr>
		<tr>
			<td>Dielectric mirror</td>
			<td>Thorlabs</td>
			<td>BB1-E03</td>
			<td>Used to reflect light along the optical path</td>
		</tr>
		<tr>
			<td>Endocavity US transducer</td>
			<td>Alpinion Medical Systems</td>
			<td>EC3-10</td>
			<td>Transvaginal ultrasound probe</td>
		</tr>
		<tr>
			<td>Laser power meter</td>
			<td>Coherent</td>
			<td>LabMax TOP</td>
			<td>Used to measure laser energy</td>
		</tr>
		<tr>
			<td>Multi-mode optical fiber</td>
			<td>Thorlabs</td>
			<td>FP1000ERT</td>
			<td>Couple laser light to the endocavity ultrasound probe</td>
		</tr>
		<tr>
			<td>Non-polarizing beam splitter plate</td>
			<td>Thorlabs</td>
			<td>BSW11</td>
			<td>For splitting laser beam into sensors to measure energy</td>
		</tr>
		<tr>
			<td>Plano-concave lens</td>
			<td>Thorlabs</td>
			<td>LC1715</td>
			<td>For laser beam expansion</td>
		</tr>
		<tr>
			<td>Plano-convex lens&#160;</td>
			<td>Thorlabs</td>
			<td>LA1484-B</td>
			<td>For laser beam collimation</td>
		</tr>
		<tr>
			<td>Plano-convex lens&#160;</td>
			<td>Thorlabs</td>
			<td>LA1433-B</td>
			<td>Used to focus light into four optical fibers</td>
		</tr>
		<tr>
			<td>Polarizing beam splitter cube</td>
			<td>Thorlabs</td>
			<td>PBS252</td>
			<td>For splitting laser beam into four beams</td>
		</tr>
		<tr>
			<td>Protective probe shealth</td>
			<td>Custom 3D printed</td>
			<td></td>
			<td>Hold and protect the four optical fibers at the tip of the ultrasound probe</td>
		</tr>
		<tr>
			<td>Right angle prism mirror</td>
			<td>Thorlabs</td>
			<td>MRA25-E03</td>
			<td>Used to reflect light along the optical path</td>
		</tr>
		<tr>
			<td>Tunable laser system</td>
			<td>Symphotic TII</td>
			<td>LS-2145-LT50PC</td>
			<td>Light source for multispectral PAT</td>
		</tr>
		<tr>
			<td>USPAT control software</td>
			<td>Custom developed in C++</td>
			<td></td>
			<td>Controls acquisition parameters of the ultrasound machine and the laser wavelength</td>
		</tr>
		<tr>
			<td>USPAT image display software</td>
			<td>Custom developed in C++</td>
			<td></td>
			<td>Displays the US/PAT B-scans and sO2/rHbT maps in real time</td>
		</tr>
	</tbody>
</table>

a coregistered ultrasound and photoacoustic imaging protocol for the transvaginal imaging of ovarian lesions

Ovarian cancer remains the deadliest of all the gynecological malignancies due to the lack of reliable screening tools for early detection and diagnosis. Photoacoustic imaging or tomography (PAT) is an emerging imaging modality that can provide the total hemoglobin concentration (relative scale, rHbT) and blood oxygen saturation (%sO2) of ovarian/adnexal lesions, which are important parameters for cancer diagnosis. Combined with coregistered ultrasound (US), PAT has demonstrated great potential for detecting ovarian cancers and for accurately diagnosing ovarian lesions for effective risk assessment and the reduction of unnecessary surgeries of benign lesions. However, PAT imaging protocols in clinical applications, to our knowledge, largely vary among different studies. Here, we report a transvaginal ovarian cancer imaging protocol that can be beneficial to other clinical studies, especially those using commercial ultrasound arrays for the detection of photoacoustic signals and standard delay-and-sum beamforming algorithms for imaging.

Here, we show examples of malignant and normal ovarian lesions imaged by USPAT. Figure 3 shows a 50 year old premenopausal woman with bilateral multicystic adnexal masses revealed by contrast-enhanced CT. Figure 3A shows the US image of the left adnexa with the ROI marking the suspicious solid nodule inside the cystic lesion. Figure 3B shows the PAT rHbT map superimposed onto the US and shown in red. The rHbT showed extensive diffus...

Watch this Scientific Journal Video about A Coregistered Ultrasound and Photoacoustic Imaging Protocol for the Transvaginal Imaging of Ovarian Lesions at JoVE.com

A Coregistered Ultrasound and Photoacoustic Imaging Protocol for the Transvaginal Imaging of Ovarian Lesions

We report a coregistered ultrasound and photoacoustic imaging protocol for the transvaginal imaging of ovarian/adnexal lesions. The protocol may be valuable to other translational photoacoustic imaging studies, especially those using commercial ultrasound arrays for the detection of photoacoustic signals and standard delay-and-sum beamforming algorithms for imaging.

Ovarian cancer remains the deadliest of all the gynecological malignancies due to the lack of reliable screening tools for early detection and diagnosis. ...

a-coregistered-ultrasound-photoacoustic-imaging-protocol-for

Research

Education

JoVE Core

JoVE Journal

Electrical Engineering

Engineering

Unit 1

Root-Locus Method

SCIENTISTS IN ACTION

1.3K vistas.  Washington University. Como todos sabemos, el cáncer de ovario es el más mortal de todos los tumores malignos ginecológicos, cuando el cáncer de ovario se detecta en una etapa más temprana y localizada, la cirugía y la quimioterapia pueden curar alrededor del 70 al 90% de las pacientes en comparación con solo el 20% o menos cuando se diagnostica en las etapas posteriores. Y se sabe que los métodos estándar de atención actuales tienen una sensibilidad más baja para la detección temprana del cáncer de ov...